Omadacycline is an antibiotic used to treat community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI). It works by inhibiting bacterial protein synthesis via the 30S ribosomal subunit. Marketed as Nuzyra, it’s available in both oral and IV forms. It is grouped under the following drug class(es): Tetracyclines. Its therapeutic use is listed as anti-infectives, antibacterials and antibiotics. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Amadacycline, nuzyra, omadaciclina and 9-neopentylaminomethylminocycline. Its PubChem CID is 54697325.
Omadacycline
| CAS No | 389139-89-3 |
|---|---|
| Molecular Formula | C29H40N4O7 |
| Molecular Weight | 556.6 g/mol |
| Synonyms | (4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-9-[(2,2-dimethylpropylamino)methyl]-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Omadacycline is an antibiotic used to treat community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI). It works by inhibiting bacterial protein synthesis via the 30S ribosomal subunit.
The listed CAS number is 389139-89-3.
The listed molecular formula is C29H40N4O7.
The listed molecular weight is 556.6 g/mol.
(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-9-[(2,2-dimethylpropylamino)methyl]-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide.
The source lists Amadacycline, nuzyra, omadaciclina and 9-neopentylaminomethylminocycline.